Recombinant Human Defb4 Protein，His

Defb4, also known as the defensin beta 4, is a member of the beta-defensin family of antimicrobial peptides, which play a crucial role in the innate immune response. Identified primarily in epithelial tissues, Defb4 is known to exhibit broad-spectrum antimicrobial activity against bacteria, fungi, and some viruses. Its expression is usually upregulated in response to infections or inflammatory conditions, highlighting its importance in host defense mechanisms. Recent studies have revealed that Defb4 not only functions as an antimicrobial agent but also modulates immune cell responses and contributes to wound healing processes. Given the rising concern over antibiotic resistance, research into Defb4 and related peptides has garnered significant attention in the fields of immunology and microbiology. Scientists are exploring the potential of Defb4 as a therapeutic agent, either in its natural form or as a designed recombinant protein, to combat multidrug-resistant infections. Understanding the structure, function, and regulation of Defb4 can provide insights into its mechanisms of action and pave the way for novel therapeutic strategies that exploit its immunomodulatory properties. As further studies are undertaken, Defb4 holds promise not only for developing new antimicrobial therapies but also for enhancing existing treatment protocols against stubborn infections, making it a focal point of current biomedical research.